AKT1 and breast carcinoma: Activating somatic mutations of other oncogenes (EGFR, KRAS, HRAS, NRAF, BRAF and AKT1) involved in downstream molecular events following tyrosine kinase receptor activation are frequent in several malignancies but rare in breast cancer.